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A systematic review of diagnostic techniques to determine tissue perfusion in
patients with peripheral arterial disease
Kirsten F. Ma*a, Simone F. Kleiss*a, Richte C.L. Schuurmanna, Reinoud P.H. Bokkersb, Çagdas Ünlüc and Jean-Paul P.
M. De Vriesa
aDepartment of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;
bDepartment of Vascular Surgery, Noordwest Hospital Group, Alkmaar, The Netherlands; cDepartment of Radiology, Medical Imaging Center,
University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
ABSTRACT
Introduction: Peripheral arterial disease (PAD) may cause symptoms due to impaired tissue perfusion of
the lower extremity. So far, assessment of PAD is mainly performed by determination of stenosis or
occlusion in the large arteries and does not focus on microcirculation. Several diagnostic techniques
have been recently introduced that may enable tissue perfusion measurements in the lower limb;
however, most have not yet been implemented in clinical daily practice. This systematic review provides
an overview of these diagnostic techniques and their ability to accurately detect PAD by peripheral
tissue perfusion.
Areas covered: A literature search was performed for articles that described a diagnostic technique to
determine tissue perfusion in patients with known PAD compared with healthy controls.
Expert opinion: So far, transcutaneous oxygen measurements are most often used to measure tissue
oxygenation in PAD patients, but evidence seems too low to define this technique as a gold standard,
and implementing this technique for home monitoring is difficult. New potentially suitable diagnostic
tests should be non-invasive, contact-free, and quick. Further research is needed for all of these
techniques before broad implementation in clinical use is justified, in hospital, and for home
monitoring.
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Peripheral arterial disease (PAD) is a common disease [1–4]. The
number of people with PAD worldwide has increased by 24% in
the past 10 years [5]. Patients with PAD often suffer from
decreased mobility, severe pain, lower quality of life, and multi-
ple morbidities. Within 10 years after being diagnosed with PAD,
2% of the patients will undergo major limb amputation [3]. The
first symptomatic stage of PAD is usually manifested by inter-
mittent claudication, which progresses into chronic limb-
threatening ischemia (CLI) in 15% of these patients. PAD does
not progress linearly from claudication to CLI in every patient.
Sometimes patients develop CLI without ever having claudica-
tion. Accurate and easy accessible diagnostic techniques are
necessary for early detection and treatment of PAD.
Many invasive and non-invasive techniques are available
for assessing diminished arterial inflow of blood caused by
PAD. The ankle/brachial index (ABI) is clinically the most used
non-invasive measurement [2,4,6]. Other non-invasive diag-
nostic methods include Doppler color ultrasound imaging,
toe systolic blood pressure, and the treadmill test [7]. Besides
non-invasive diagnostics, more invasive techniques using
intravenous contrast agents are performed for detection of
stenosis or occlusion of the macrovasculature, such as
computed tomography angiography (CTA), digital subtraction
angiography (DSA), or magnetic resonance angiography
(MRA). All these techniques, however, focus on blood flow in
the larger arteries of the lower extremity and are not able to
assess the microcirculation and saturation of peripheral tissue.
Several techniques have been recently introduced that may
enable tissue perfusion measurements in the lower extremity.
Studies with non-invasive techniques include hyperspectral
imaging (HSI), laser Doppler perfusion imaging (LDPI), laser
speckle contrast imaging (LSCI), near-infrared (NIR) spectro-
scopy (NIRS), spectrophotometry, transcutaneous oxygen
measurements (TcPO2) and vascular optical tomography ima-
ging (VOTI). Other diagnostic techniques using endogenous or
exogenous contrast agents include magnetic resonance perfu-
sion imaging (MRI perfusion), contrast-enhanced ultrasound
(CEUS) and NIR fluorescence imaging with indocyanine green
(ICG). All of these techniques focus on assessment of the
microcirculation of the skin or muscle in the lower extremity,
but act on different mechanisms.
The aim of this systematic review is to provide an overview
of diagnostic techniques that are currently available to deter-
mine tissue perfusion in patients with PAD and healthy con-
trols. We will discuss the techniques according to their ability
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and quality assessment to detect PAD when tissue perfusion in
healthy controls is compared with patients with known PAD.
2. Methods
This systematic review was conducted in accordance to the
Preferred Reporting Items for Systematic Review and Meta-
Analysis (PRISMA) statement [8]. The review protocol was pro-
spectively registered in the PROSPERO database.
2.1. Literature search
Four electronic databases were searched for eligible articles:
PubMed, EMBASE, CINAHL, and Cochrane Central Register of
Controlled Trials. The search was performed with the help of
Medical Subject Headings terms for “peripheral arterial disease’’,
“diagnostic techniques’’, “microcirculation’’ and “lower extremity’’.
The complete search strategy is available in Appendix 1. Studies
published between January 2009 and January 2019 were consid-
ered. Titles and abstracts of the studies were independently
reviewed by two authors (KFM, SFK), blinded to the authors and
journal titles. Items in which there was disagreement were dis-
cussed by the two screeners. Articles considered for inclusionwere
independently reviewed by the two authors, and consensus was
reached for inclusion. If consensus could not be reached, adjudica-
tion from a third author (JPdV) was sought.
2.2. Selection criteria
Articles were eligible if they included a diagnostic technique to
determine tissue perfusion. Selected studies had to determine
tissue perfusion in patients with PAD and compare this to tissue
perfusion in healthy controls. The included articles were published
in English, included human subjects, and had a full text available.
Exclusion criteria were case reports, case-series studies,
studies with fewer than 10 participants, reviews, commen-
taries, letters to the editor, or conference abstracts. Studies
investigating the correlation between tissue perfusion and
clinical outcomes without comparison to healthy controls
were excluded, as were studies investigating the use of tissue
perfusion measurements to determine effect of treatment.
Studies using hyperemia and exercise testing before the mea-
surements of tissue perfusion were excluded, except for stu-
dies describing baseline measurements before hyperemia or
exercise testing.
2.3. Data extraction and quality assessment
Study details were extracted from the articles using
a predefined abstract form and categorized according to diag-
nostic tests for measuring tissue perfusion. The following data
were extracted: study design, number of patients and healthy
controls, the method of assessing PAD, characteristics of the
measurement protocol, and outcome. The outcome of interest
was the differences in tissue perfusion between PAD patients
and healthy controls. The technical properties and clinical
application within PAD are described for each technique.
Statistical comparison and accuracy of the diagnostic techni-
ques was scored if available in the included studies. Data were
collected using Review Manager 5.3. software (The Nordic
Cochrane Centre, the Cochrane Collaboration, 2014,
Copenhagen, Denmark). Quality assessment of the studies
was performed according to the Quality Assessment of
Diagnostic Accuracy studies (QUADAS-2) method [9].
3. Description of techniques and main results
The search resulted in 3129 records, of which 859 were duplicates
or irrelevant to the topic. After detailed evaluation of the titles and
abstracts, 205 articles were selected for full-text assessment. After
assessment of these 205 articles, 20 articles were found to be
eligible for inclusion. Of the remainder, 89 were excluded because
no comparison was made between PAD and healthy controls, 58
could not be assessed because only an abstract was available, 20
articles were excluded due to the use of hyperemia or exercise
testing, and 18 articles for other reasons. The review process is
outlined in detail in Figure 1.
Studies are categorized according to the diagnostic technique.
In Table 1, data extraction is provided for perfusion measurement
techniques that were investigated in more than two studies in the
literature. These techniques will be described in more detail in the
text. Table 2 summarizes the diagnostic techniques that are
described in fewer than two studies. In two articles, Chiang et al.
[10] and Pawlaczyk et al. [11], not one but two different perfusion
measurement techniques are described. Bias and quality assess-
ment with Quadas-2 is shown in Figures 2 and 3, respectively.
3.1. CEUS assessment
3.1.1. Technical background
CEUS uses microbubbles to assess themicrovascular blood flow in
patients with PAD. The microbubbles increase the intensity of
Doppler signals from the blood for several minutes after injection
and are 1000 times more reflective than body tissue. They can
expand and contract through pressure changes of soundwaves of
the ultrasound beam and vibrate strongly especially at high fre-
quencies [13]. The microbubbles, with a diameter that varies
between 1 and 5 µ, cannot penetrate the endothelium but are
able to traverse the microcirculation [14].
3.1.2. Application within PAD
Three prospective studies investigated the use of CEUS in PAD, as
reported in Table 1. Duerschmied et al. [15], Kundi et al. [14], and
Meneses et al. [16] published prospective cohort studies and used
different types ofmicrobubble contrast agents. These three studies
Article highlights
● Assessment of peripheral arterial disease is mainly performed by
determination of stenosis or occlusion in the large arteries and
does not focus on microcirculation.
● Available diagnostic techniques for measurement of tissue perfusion
in the lower extremity that may be implemented in clinical and home
settings are reviewed, including the quality of publications.
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measured muscle perfusion, but on different spots at the lower
limb.
Duerschmied et al. [15] analyzed time intensity curves and
compared the time to peak (TTP) intensities between 58 healthy
controls and 52patientswith PAD. The TTP intensity is theduration
from the increase in contrast density until its peak. They showed
a significant difference between these two groups (36.9 seconds
versus 18.9 seconds, p < 0.001).
Kundi et al. [14] included 13 patients with PAD and 8 healthy
controls. TTP and peak perfusion (PEAK) at rest were not sig-
nificantly different between PAD patients and healthy controls.
Meneses et al. [16] determined whole-leg blood flow and vas-
cular conductance in both groups sitting and when supine. Both




MRI is capable of producing three-dimensional detailed anatomi-
cal imaging by measuring the interaction between an external
magnetic field and protons within the body after applying
radiofrequency pulses. MRI perfusion imaging is facilitated by
means of exogenous and endogenous contrast agents. Contrast-
enhanced perfusion techniquesmeasure the T1 or T2/T2* effect of
paramagnetic contrast agents, such as gadolinium, on tissue using
T1- or T2-weighted imaging sequences [17].
Arterial spin labeling (ASL), blood oxygen level-dependent
(BOLD) imaging, and intravoxel incoherent motion (IVIM) are per-
fusion techniques that do not require administration of an exo-
genous contrast agent. In ASL, arterial blood is used as an
endogenous contrast agent bymagnetically labeling the inflowing
blood with radiofrequency pulses. Perfusion contrast is given by
the difference in magnetization between a labeled and unlabeled
control image induced by the exchange ofmagnetization at tissue
level [18]. Becausemost ASLMRI techniques acquire the perfusion-
weighted images at a fixed time after the initial labeling of the
arterial blood, it might be that the magnetic label may not reach
the imaging plane, leading to an underestimation of peripheral
blood flow. BOLD MRI has been based on the paramagnetic
properties of deoxyhemoglobin as an intrinsic contrast agent
[19]. An increase of tissue perfusion results in a higher oxyhemo-
globin and lower deoxyhemoglobin concentration in the small
vessels and local microcirculation of PAD patients. IVIM is based
Figure 1. Flowchart for the selection process of included studies.

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































EXPERT REVIEW OF MEDICAL DEVICES 703
on diffusion-weighted imaging (DWI) using different b-values to
measure the signal intensity of diffusion. Quantitative parameters,
such as the diffusion coefficient, pseudodiffusion coefficient, and
the relative perfusion fraction, can be calculated [20].
3.2.2. Application within PAD
Three prospective studies were found describing the use of
MRI perfusion in PAD, as reported in Table 1. Jiji et al. [21]
included 11 patients with PAD (ABI >0.4 and <0.9) and 16
Figure 2. Bias and quality assessment of the included studies according to QUADAS-2.
704 K. F. MA ET AL.
healthy controls to determine the reproducibility and utility of
measurements at rest by contrast-enhanced calf perfusion
MRI. They generated a time intensity curve, whereby the
slope of the curve represented the tissue function. Results
showed no difference in tissue function between patients
with PAD and healthy controls.
Englund et al. [22] used ASL and BOLD imaging to assess
tissue perfusion in the skeletal muscle of 10 individuals (five
patients with PAD and five healthy controls). The method that
they used was called Perfusion, Intravascular Venous Oxygen,
and T2* (PIVOT) and mean baseline T2* values showed a 1 ms
difference (not significant) between patients suffering from
PAD versus healthy controls.
Suo et al. [23] integrated ASL, BOLD and IVIM MRI imaging
in a single-experimental setup and investigated the ability of
these techniques to diagnose and asses the severity of PAD.
They included 14 patients with PAD and 10 healthy controls.
Baseline T2* values of BOLD MRI (ms), ASL-blood flow (mL/
100 g/min) and IVIM-f (%) were specified for different muscle
groups between age-matched healthy controls and patients
with PAD. According to Suo et al. [23] T2* was the only
perfusion-related parameter that showed significant differ-
ences between age-matched healthy controls and patients
with PAD. Values derived from four muscle groups in the
lower extremity are provided in Table 1.
3.3. Near-infrared spectroscopy
3.3.1. Technical background
NIRS is a non-invasive technique to determine muscle tissue
oxygenation [24–26]. Wavelengths of red and NIR laser light
illuminate the tissue at a depth of 1 to 3 cm, depending on the
device used. The devices consist of a laser light source and
photo detectors. The light is partly absorbed and scattered by
the examined tissue, and the light that is reflected back is
recorded by the detectors. NIRS uses the absorption spectra of
the tissue chromophores oxyhemoglobin and deoxyhemoglo-
bin to calculate the tissue saturation. These values can be
expressed as tissue oxygen saturation (StO2), regional hemo-
globin oxygen saturation (rSO2) or skeletal muscle oxygen
saturation (SmO2) [27–30].
3.3.2. Application within PAD
Four prospective cohort studies investigated the use of NIRS in
PAD. Mesquita et al. [28] studied NIRS in 26 patients with PAD
and 31 healthy controls. PAD assessment was done with ABI,
and participants were categorized in a healthy group (ABI
>0.9), and two patient groups: mild PAD (ABI >0.7 to <0.9)
and severe PAD (ABI >0.3 to <0.7). Results show that StO2 was
significantly lower in patients with PAD than in healthy con-
trols (severe PAD: 54.2, mild PAD: 53.0 versus 63.5 in controls;
p < 0.05).
Kagaya et al. [29] investigated 20 patients with PAD and 20
healthy controls. Assessment of PAD was done according to
Rutherford classification. Only patients with Rutherford 4, 5, or
6 were included. Results show significantly lower StO2 values in
patients with PAD compared with healthy controls.
Boezeman et al. [27] studied 61 patients with PAD and 30
healthy controls. Assessment of PAD was performed by diag-
nostic imaging, and afterward, patients were categorized in
Fontaine classification 3 or 4. Results showed significantly
lower rSO2 at all but one of the examined area’s on the
lower extremity and upper arm (Table 1). The area of the
proximal part of the upper leg was not suitable for examina-
tion because of the thickness of the skin.
Miller et al. [30] included eight patients with PAD and eight
healthy controls. PAD was assessed by an ABI <0.9, and all
patients were classified as Fontaine 2. The results of this study
showed no significant difference in SmO2 between PAD
patients and healthy controls.
3.4. Transcutaneous oxygen measurements
3.4.1. Technical background
TcPO2 is a non-invasive imaging method to quantify skin oxy-
genation. The Clark electrode that is used is based on ampero-
metry and consists of several components: a voltage source,
an electron receiver, an electron donor, an electrolyte solution,
and a permeable membrane. The electron donor is placed in
the electrolyte solution to produce electrons. The electrode
can be heated from 37°C to 45°C on the skin surface, which
causes capillaries to dilate and oxygen to be released. The
higher the oxygen in the tissue, the more oxygen reacts with
the electrons at the electron receiver and PO2 can be mea-
sured [31]. TcPO2 has been claimed to predict wound healing
and asses PAD [10].
3.4.2. Application within PAD
Three prospective cohort studies investigated the use of TcPO2
in PAD. Pawlaczyk et al. [11] included 79 patients with
Rutherford classes 0 to 1, 137 patients with Rutherford classes
3 to 4, and 27 healthy controls. TcPO2 was significantly lower in
patients with PAD compared with healthy controls (class 0 to
Figure 3. Graphical display is bias and quality assessment according to QUADAS-2.
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1: 19.76 ± 12.2, class 3 to 4: 47.54 ± 14.86 versus 64.30 ± 7.25
in controls; p < 0.001).
Chiang et al. [10] focused on the comparison of different
techniques, including TcPO2 measurements. This prospective
study included 150 PAD patients and 20 healthy controls. The
PAD patients were subdivided according to Rutherford classi-
fication. TcPO2 and TcPCO2 values were stated for PAD patients
and healthy controls; however, a statistical comparison
between the groups was not performed.
The third included study, by Kovacs et al. [32], showed
significantly lower values for PAD patients compared with
healthy controls (42 ± 15 versus 55 ± 9; p < 0.005). The authors
measured Doppler ultrasound, TcPO2, and toe pressure at rest




HSI determines spectroscopy values of oxyhemoglobin and
deoxyhemoglobin [33–36]. Wavelengths of visible light illumi-
nate and penetrate the upper 1 to 2 mm of the skin.
A spectrometer within the camera collects the light that is
reemitted by the skin [37]. From the collected light, data are
represented as a hypercube [33]. Each pixel in a hypercube
represents the local reflectance spectrum of the tissue at
a specific location with a size of 0.1 mm. From these differ-
ences in absorption spectra, spectroscopy can be performed
to determine oxygenation levels of the tissue.
3.5.2. Application within PAD
Two prospective cohort articles investigating tissue perfusion
with the OxyVu Hyperspectral imaging Tissue Oxygenation
Mapping System (HyperMed Inc. Memphis, TN) have been
published [10,38]. The authors used a skin target with an
area of 204 mm2 and calculated the oxyhemoglobin and
deoxyhemoglobin values in a region of interest of 1 cm
around the target [35,39,40]. Overall oxygen saturation of the
skin is calculated as oxy/(oxy+deoxy) × 100%. Chiang et al.
[10] compared hyperspectral oxygen saturations with TcPO2
and TcPCO2 values and showed a strong relationship between
deoxyhemoglobin and TcPCO2 (p = 0.0001).
3.6. Laser Doppler perfusion monitoring
3.6.1. Technical background
Laser Doppler perfusion monitoring (LDPM) uses NIR laser
light with a wavelength of 780 nm to measure tissue perfusion
of the skin [11,41]. The penetration depth of the laser is
approximately 0.3 to 0.5 mm [42]. The light is scattered or
partly absorbed by the skin and subcutaneous tissue. The light
that is reflected by the red blood cells will change due to the
Doppler effect [43]. The frequency of the light is changed by
the reflection and detected with use of an optical fiber. The
measurements of the skin microcirculatory blood flow are
expressed in perfusion units (PU) [44].
3.6.2. Application within PAD
One prospective study has been published using LDPM, as
listed in Table 1. Pawlacyzk et al. [11] studies LDPM in 216
patients with PAD and 27 healthy controls. Results showed no
significant differences between patients with varying
Rutherford degrees and healthy controls.
3.7. Laser speckle contrast imaging
3.7.1. Technical background
LSCI is based on laser light to visualize the microcirculation of
the skin [43,45–47]. Light is scattered back from the skin,
creating an interference pattern called a laser speckle pattern.
The speckle pattern images changes in time, mainly due to the
flow of red blood cells in the microcirculation [48]. This leads
to blurring of the speckle pattern, which will cause change in
laser speckle contrast. The images are recorded, and the blood
perfusion can be expressed as an arbitrary unit, PU, or LSCI
index [45]. An additional parameter that can be calculated
from LSCI is the beat strength of skin perfusion (BSSP). This
is an average amplitude of dynamic cutaneous blood flow
changes, synchronized with heart beats [46].
3.7.2. Application within PAD
Two prospective studies investigated the use of LSCI in PAD. The
details are reported in Table 1. Both studies concluded that LSCI
values were significantly lower in PAD patients compared with
healthy controls in every measured location on the foot.
3.8. NIR fluorescence imaging with ICG
3.8.1. Technical background
The principle of fluorescence imaging is to illuminate contrast
agents, for example ICG with an absorption maximum at
800 nm. The region of interest in a tissue is illuminated with
NIR light at a wavelength of 750 to 800 nm while observing
with the camera at longer wavelengths (700–900 nm) [49,50].
3.8.2. Application within PAD
Two articles have been published on NIR fluorescence imaging
with ICG as a contrast agent. One was a retrospective cohort
study [51] and the other a clinical pilot study [52].
Igari et al. [51] included 14 patients with PAD and 9
patients without PAD to evaluate the accuracy of ICG angio-
graphy to diagnose PAD. Quantitative parameters, such as the
magnitude of intensity from ICG onset to the maximum inten-
sity (Imax) and the half value of the maximum intensity (T1/2),
showed no significant difference between PAD and controls.
However, the time from ICG onset to maximum intensity (Tmax)
, the time elapsed from the maximum intensity to 90% of the
Imax and to 75% of the Imax (Td 90% and Td 75%), and the rate
of intensity measured 60 sec after the Tmax to the Imax (IR
60 seconds) were significantly different. The authors investi-
gated the accuracy of the diagnostic technique and showed
a sensitivity of 82.6% and specificity of 73.3% after setting the
highest diagnostic value of Td 90% as the cutoff (25 seconds).
Kang et al. [52] showed a sensitivity of 92% and a specificity
of 90% with a set value of 24.4%/min perfusion rate as the
706 K. F. MA ET AL.
cutoff. They included 34 participants (10 healthy controls and
24 PAD patients) and found significantly higher values for
healthy controls than for PAD patients.
3.9. Spectrophotometry
3.9.1. Technical background
Spectrophotometry, or micro-lightguide spectrophotometry is
a non-invasive technique for determining microcirculation in
the skin by means of continuous white and laser light [53,54].
The white light that is scattered by the tissue chromophores and
the wavelength-dependent absorption spectra are both
recorded [55]. The amount of reflected laser light is changed
by the movement of red blood cells and collected to determine
blood flow. The spectrophotometry determines the oxygen
saturation, which is expressed as an arbitrary unit (SO2) [56].
3.9.2. Application within PAD
One prospective cohort study was found in the literature
search [56]. Details are provided in Table 1. Results showed
that SO2 was significantly lower in patients with PAD than in
healthy controls. There were no significant differences
between the groups.
3.10. Vascular optical tomography imaging
3.10.1. Technical background
VOTI is a non-invasive, contrast-free imaging modality that
uses NIR light to illuminate the tissue of interest. Back-
scattered light and light that is transmitted through the foot
is captured by a detector. Spatial maps of hemoglobin can be
produced, which can be translated to total hemoglobin (HbT)
time traces within a region of interest.
3.10.2. Application within PAD
One diagnostic pilot study by Khalil et al. [57] describes the
use of VOTI in PAD in a pilot study of 10 PAD patients and 20
healthy controls. No statistical analyses were performed in
rest.
4. Discussion
Assessment of microcirculation is essential to diagnose PAD,
because symptoms of chronic limb-threatening ischemia are
a direct result of insufficient tissue perfusion. However, the
decision making in treatment of PAD patients is still mainly
based on diagnostics regarding the macrovasculature. Also,
the post-treatment follow-up is focused on patency of the
large lower limb arteries and less on the status of the
microcirculation.
This systematic review provides an overview of the current
available diagnostic techniques to determine tissue perfusion
in PAD patients and healthy controls. We identified 20 studies
describing 10 different techniques. Comparing results and
drawing firm conclusions is difficult because of substantial
heterogeneity in different aspects, such as inclusion criteria,
diagnosis and severity of PAD, vascular risk factors, and comor-
bidity of patients, and the selection of healthy controls.
Another limitation is that most of the studies included
a (too) small number of patients and controls, except for the
studies with focus on TcPO2 measurements. To compare new
diagnostic techniques, such as HSI and LSCI with TcPO2 more
large prospective cohort trials should be performed. 13 of the
20 studies are at risk of bias when assessing the index test and
reference standard. The reason for this is that in these studies
no details were provided who performed the index test and
reference standard and whether these measurements were
performed blinded.
It is also important to consider the different technical work-
ing mechanisms of the diagnostic techniques described in this
systematic review. Most of these techniques measure the
blood flow or blood circulation in a specific region of interest
in tissue. Examples are contrast-enhanced ultrasound, MRI
perfusion, laser Doppler perfusion monitoring, LSCI, NIR fluor-
escence imaging with ICG, and spectrophotometry. For the
measurement of tissue composition or the concentration of
oxyhemoglobin and deoxyhemoglobin NIRS, hyperspectral
imaging, VOTI, or TcPO2 measurements should be used. Local
skin temperature is a result of various physiological factors,
such as blood flow, blood circulation, tissue composition and
oxygen saturation, and may therefore also indicate tissue
perfusion. However, this review was limited to techniques
that are indicative for one of these physiological factors.
Thermal imaging, which can be measured with various tech-
niques, including microwave radiometry thermometry [58] or
infrared thermography [59] is therefore not included in this
systematic review.
Another important difference between the diagnostic
devices is the penetration depth of the techniques. Most of
the techniques enable determination of the superficial skin
perfusion such as TcPO2, HSI, NIRS, LDPM, LSCI, Near-infrared
fluorescence imaging with ICG, spectrophotometry and VOTI.
These perfusion measurements are different from the techni-
ques such as CEUS, MRI and NIRS, that have a greater penetra-
tion depth and therefore measure muscle perfusion.
Tissue perfusion at rest in skeletal muscle in the limb is quite
low and difficult to measure for most of these techniques.
A method to increase flow such as cuff occlusion, hyperemia
or exercise can be necessary to increase sensitivity to differences
between patients with PAD and healthy controls. However,
hyperemia or exercise testing can be performed in many differ-
ent ways, which lead to an increase in heterogeneity of the
diagnostic values to determine tissue perfusion in patients
with PAD. Therefore, manuscripts focusing only on measure-
ments under hyperemic conditions or exercise were excluded
from this review. Manuscripts including measurements at rest as
well as under hyperemic conditions have been included.
TcPO2 is often seen as the gold standard to measure tissue
oxygenation. This technique is applied in several medical
fields, including pediatric intensive care and diabetic foot
ulcers [10,60]. So far, it seems reliable in differentiation
between PAD patients and controls, although the total num-
ber of included controls was <70. However, TcPO2 also has
some limitations; for example, the intra-operator variability of
TcPO2 measurements is 10% [10]. Besides, measurements
depend on the heating of the Clark electrode, which makes
these measurements time-consuming, especially when exam-
ination of multiple locations at the lower extremity and foot
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are mandatory. Moreover, this technique seems less suitable
to be used in home setting, which maybe an important fea-
ture given that telemonitoring will increase in next few years,
especially in older frail patients.
The other techniques are still in their infancy regarding
tissue perfusion determination and have some limitations.
One of the limitations of NIRS is the measurement of loca-
tions with more adipose tissue, which can cause inaccurate
values [27]. NIRS is also limited by tissue infection and inflamma-
tion. Furthermore, outcome values of NIRS are sensitive to both
oxygen delivery and oxygen extraction [30]. In PAD, using con-
tact-free methods, such as HSI, LSCI, or MRI, may be preferable,
especially when patients have foot ulcers. MR BOLD imaging is
the most reliable technique to detect and stratify microvascular
function at rest in PAD patients [23]. Disadvantages of BOLD MRI
are the limited availability and the high costs [61]. In addition,
patients are positioned in a cylindrical tube with high noise
levels, which can cause claustrophobia [62]. However, MRI
enables visualization of 3D images in contrast to HSI and LSCI,
both of which produce a two-dimensional color-coded map to
examine the tissue perfusion in the foot [10,46].
HSI and LSCI devices are easy to use and can be applied at
the patient’s bedside. One of the limitations of LSCI is the
measurement of tissue perfusion at the dorsum of the foot.
Most patients have a curvature that causes a reduced reflec-
tion of the laser, which results in inaccurate measurements
[46]. This is not the case in other techniques such as, CEUS and
fluorescence imaging. However, these techniques use
a contrast agent, by which the distribution of the contrast
agent is dependent on for example, cardiac output [15].
Nevertheless, development of these techniques is highly
important to focus on a more accurate diagnostic method to
measure tissue perfusion in patients with PAD.
5. Expert opinion
This review evaluated 10 diagnostic techniques for tissue
perfusion measurements to determine their ability to diagnose
PAD and chronic limb-threatening ischemia. Some of the
devices show promising results, but the amount of evidence
available is still insufficient to enable the routine implementa-
tion of any of the devices in clinical practice at this point.
Before a specific tissue perfusion measurement will be
implemented on a large scale, it must meet a number of
needs. First, it should determine tissue perfusion precisely
and accurately with low intra-observer and inter-observer
variability. Next, it should preferably be a noninvasive techni-
que that, is contact free and low in cost. Last, it should be
a device that can easily be used in the clinical setting as well
as in the home setting. A diagnostic technique that complies
with all of these conditions could be used to determine the
severity of PAD and would be able to monitor tissue perfusion
throughout the total treatment process.
When PAD is diagnosed based on clinical symptoms and
a significant stenosis on CTA or MRA, tissue perfusion measure-
ments should additionally be performed to determine the
microcirculation, especially around ulcers and ischemic wounds.
Tissue perfusion measurements after revascularization are also
important, because a technically successful revascularization
does not always lead to clinical improvement such as pain relief
or ulcer healing.
Home monitoring or telemedicine will evolve over the
coming years because of an increasing demand as a result of
the aging patient population. The elderly patient population
often suffers from cardiovascular diseases, causing frailty and
low mobility. Therefore, home monitoring of tissue perfusion
with non-invasive devices will become more and more impor-
tant, not only in patients with PAD but also in patients with
diabetes, who are prone to develop foot ulcers. Tissue perfu-
sion measurements with LSCI or HSI could be potentially
successful in accomplishing this, because they depend on
non-invasive, non-contact measurement. Measurements
should be performed in a standardized protocol by care pro-
viders to overcome variability and user dependency. It may be
an illusion that patients will be able to determine their tissue
perfusion themselves at home. However, if wound consultants
or general practitioner can measure tissue perfusion in PAD
patients the burden to expensive visits to outpatients clinics
and hospitals may decrease.
In conclusion, there is a need to determine tissue perfusion
in patients suffering with PAD and chronic limb-threatening
ischemia. The ideal tissue perfusion measurement technique is
non-invasive, with low inter-observer and intra-observer varia-
bility, inexpensive, and can be performed throughout the
entire peri-procedural process. Continuation of tissue perfu-
sion measurements in the first weeks postintervention at
home may be important to evaluate clinical outcomes. So
far, evidence is scarce regarding such techniques, and large
prospective trials are necessary before tissue perfusion mea-
surements are incorporated in daily vascular practice.
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